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ABSTRACT 
Production risk from live weight variation of market pigs has become a more important 
concern in U.S. swine production. Packers are concerned about the variation in carcass 
size because of the demand for standardized cuts and the use of automation in the 
slaughter process. Swine producers care about standardized pigs because of revenue 
implications and possible links to animal health and productivity. Pig size variation can 
be due to various condition and inputs including antibiotics. However, discussions on risk 
reduction from antibiotic use have generally not been considered. Our work extends 
previous studies by systematically examining the aspects of production risk reduction and 
highlights the potential results of banning antibiotics from a risk perspective. 
Using data from National Animal Health Monitoring System 2000 survey data and 
PigCHAMP, we identify the relationship between antibiotic use and production risk by 
an econometric model. Applying production costs for feeder to market pigs and a price 
matrix, the uncertainty in profits is evaluated. The impacts of risk on the decision making 
of swine producers are examined under the framework of expected utility and stochastic 
dominance analysis.  
Our results show that production risk from weight variability of market hogs is 
important in determining profits and utility under a pricing system. Production risk (i.e. 
weight gain variability) is related to the use of sub-therapeutic antibiotics. Swine 
producers could decrease production risk and enhance utility by adjusting antibiotic use. 
These results offer some support for optimal use of sub-therapeutic antibiotics.  
Keywords:  production risk, antibiotics, swine, utility, stochastic dominance. 
JEL Codes: Q10, Q12, Q14.  
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Do Antibiotics Reduce Production Risk for U.S. Pork Producers? 
X. Liu     G. Miller    P. McNamara 
Introduction 
Production risk from weight variation of market pigs has become a more important 
concern in U.S. swine production.  Packers concern about carcass size variation is partly 
because of the use of automation in the slaughter process and partly because of the desire 
to provide customers with more consistent cuts.  Swine producers also care about weight 
variation because non-uniformity of weight is costly due to price penalties for pigs 
marketed at weights outside defined weight intervals. Standardized market pigs reflect 
the needs and desires of swine producers, packers and consumers. 
Production risk mitigation has been investigated in the context of some marketing 
mechanisms, including insurance, futures markets and production contracts (Kliebenstein 
and Lawrence). Though used extensively, these risk reduction methods are not effective 
in dealing with production risk from variation in pig weight. In fact, contracts with 
packers that require shipment of pigs on specific dates may increase producer risks. Input 
management can control production risk. One example might be to use antibiotics at sub-
therapeutic levels in pig production to decrease variation in pig weights, and hence 
decrease variation in revenue received. 
The impacts from sub-therapeutic use of antibiotics on average daily gain and feed 
conversion ratio have been examined in many studies (Miller et al.; Hays; Hayes et al.; 
Zimmerman; Cromwell; Losinger et al.). However, earlier studies did not examine in 
detail the risk reduction impacts from antibiotic use. Thus, this study extends earlier work  
  4 
on the impacts from antibiotics in swine feeds by integrating risk reduction, and 
highlights some perspectives of the potential results of banning antibiotics. 
We establish relationships between antibiotic use and production risk by an 
econometric model. Using the results from the model, we evaluate the impacts of risk on 
the decision making of swine producers under the framework of expected utility and 
stochastic dominance analysis. The study is aimed to clarify that production risk from 
weight variation of market hogs is an important factor in profit and utility, to demonstrate 
the effects of risk on the decision process of the U.S. swine producers. In the end, the 
study will illustrate that antibiotic use is an effective way to reduce production risk and 
improve economic returns.   
 
Theoretic Framework 
Production risk represents an important dimension of livestock production. It can 
significantly influence the decision making of risk averse producers. Decisions under 
conditions of uncertainty have usually been modeled in the framework of expected utility 
and stochastic dominance analysis. 
Dillon (1977) examined the problem of uncertainty in livestock production. Based on 
his discussion, inputs in swine production could be categorized into controllable inputs, 
predetermined inputs and uncontrollable inputs. The controllable inputs can be 
determined by swine producers at the time of decision-making. In swine production, 
controllable inputs include rations, antibiotic use, and bio-security measures. The 
predetermined inputs are those that are known, but usually determined in advance of a 
production stage or outside of the swine production system. Predetermined inputs include  
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inputs such as major facilities, the genetics of pigs, geographic location of the farm, and 
some environmental factors. Uncontrollable inputs might include weather, possibly 
prevalence of a specific disease pathogens, and micro-ecology. Uncontrollable inputs can 
often be known to swine producers at the time of decision-making, but their occurrence 
may not be controlled. 
Pork producers face significant production risks. Production relates in part to 
uncontrollable inputs, and these risks may never be eliminated. Nevertheless, it is 
possible to reduce production risk by managing controllable inputs that have some 
relationships with uncertain inputs. We express our production model as follows. 
(1.1)   ) m ....x l x l ;x l ....x k x k ;x k ....x x F(x y 2 1 2 1 2 1 + + + + =  
Here y represents the random production yields,  k x x x .... 2 1  a set of controllable inputs, 
l x k x k x .... 2 1 + +  a set of predetermined variables, and  m x l x l x .... 2 1 + +  represents a set of 
uncertain variables. The uncertainty in y comes from  m x l x l x .... 2 1 + + . If relationships 
exist between set  k x x x .... 2 1  and set  m x l x l x .... 2 1 + + , then  k x x x .... 2 1 could be used to adjust 
production risk. 
Uncertainty in output can influence producer profits, and make profits a random 
variable given as   
(1.2)   ) .... 2 1 / ) (( ) (
1
k x x x F x c y y p h h
k
i
i i − − = ∑
=
π  
where py is the price for market hogs, ci is the price for a controllable input xi, F is the 
fixed costs, and  k x x x .... 2 1 is the set of controllable inputs. Thus, h(π) represents the  
  6 
profit distribution conditional on variability of production yields that are related to the 
controllable input set.  
 
Decision under Utility Maximization  
Under conditions of uncertainty in profits, swine producers make their decisions based on 
maximization of their expected utility. If an input combination X (a given input vector) 
leads to a profit set {π}, then the utility for selection of X is equal to  
(1.3)   π π π π π d X h u u E U ) / ( ) ( )) ( ( ) ( ∫ ∞
∞ − = =  
The value of equation (1.3) depends on the functional form of utility and the outcome 
distribution. Equation (1.3) could be approximated by using Taylor expansion of the 
distribution. When the first two moments are used, the decision process under conditions 
of uncertainty can be modeled as  
(1.4)  
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Equation (1.5) characterizes the marginal utility of a utility maximizing producer 
under uncertainty.  For risk neutral producers, uncertainty in profits will not affect the 




U . For risk averse producers, the utility differs with varying risk,  
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U . In most economic analyses, producers are assumed to be risk averse. Thus, 
variability in production influences producer welfare, and producers have incentives to 
reduce the risk by using controllable variables. 
 
Decision Based on Stochastic Dominance 
Expected utility analysis, although theoretically robust, is difficult to apply because of the 
need to identify the utility function. In comparison, stochastic dominance analysis (SD) 
places few restrictions on the utility functions. Using SD, decisions are guided by the 
entire cumulative distribution function (CDF) of outcome. SD application is a robust 
alternative to the use of expected utility theory (Hardaker et al.; Dillon) 
SD analysis methods often include first, second, and third order stochastic 
dominance- FSD, SSD, and TSD, respectively. For a probability density function f(x), we 
define  ∫ = =
R
a
f dx x f x F x D ) ( ) ( ) (
1    ∫ =
R
a
f f dx x D x D ) ( ) (







f dx x D x D ) ( ) (
1 .  By 
FSD, we mean that a probability density function f (x) is dominant to another probability 
density function g (x) if  ) ( ) (
1 1 x D x D g f ≤  for all values of R∈[a, b] and for at least one value 
of R  ) ( ) (
1 1 x D x D g f < . FSD illustrates the behavior of decision makers who prefer more 
profits to less, but fail to find the dominance relation when the CDF’s of available 
alternatives cross. SSD may rank these decision alternatives. SSD would conclude that a 
probability distribution f(x) is dominant to the probability distribution g(x) if 
) ( ) (
2 2 x D x D g f ≤   for all values of R∈[a, b] and  ) ( ) (
2 2 x D x D g f <  for at least one value of R. An 
identified dominance under SSD implies that decision makers prefer more profits to less, 
but also prefer less risk to more for all values of R∈[a, b]. SSD may not identify  
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dominance between distributions in some cases. TSD functions well in dealing with more 
general case. A distribution f(x) is third order dominant to another distribution g(x) if 
SSD hold  between the two and  ) ( ) (
3 3 x D x D g f ≤  for all values of R,  ) ( ) (
3 3 x D x D g f <  for at 
least one value of R. 
In general, stochastic dominance analysis has an advantage compared with utility 
maximization because of fewer constraints on utility functions. This advantage is offset 
by limitations in analytical formulation. However, such limitations are now less given 
improvements in computing techniques.  
In our study, the tests of stochastic dominance are done numerically following 
Ravallion (1994), Davidson and Duclos (1998), and Sahn and Stifel (2002). A t-test with 




f  are used to demonstrate the existence of the Sth 
order dominance between two distributions. 
 
Data  
Data in this study are from the three swine surveys conducted in 2000 by the National 
Animal Health Monitoring System (NAHMS 2000). NAHMS first survey in 2000 was of 
2333 swine producers in 17 of the major pork producing states. These 17 states accounted 
for 94 percent of the U.S. pig inventory and 92 percent of U.S. pork producers with 100 
or more pigs. Surveys of subsets of the original 2333 producers provided additional data 
on productivity measurements, managerial factors, rations, bio-security and the use of 
antibiotics.   
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Detailed information on the use of antibiotics was gathered in the NAHMS 2000 
survey. The sub-therapeutic use of antibiotics in the grower/finisher stage was well 
documented.  
Data about two dimensions of production risk, namely number of pig deaths and 
lightweight pigs, are also gathered. Both of these measures contribute to production 
uncertainty. However, here we focus our attention on only lightweight pigs since we 
previously have found no impacts from sub-therapeutic use of antibiotics on mortality 
(Miller et al. 2003)  
Our estimates of live weight of market pigs and its variability are based on NAHMS 
2000 and PigCHAMP data. Entry age, market age, ADG (average daily gain), days spent 
in the finished period, and light weight rate of pigs in the grower/finisher stage is 
available in NAHMS 2000, but entry weight and market weight are not reported. 
Benchmarking data from PigCHAMP 1999 provided the average market weight and 
variation in market weight of market hogs. These variables are used to estimate the 
market weight and its variability.   
  Data on the use of antibiotics and other input factors in swine production were also 
collected by NAHMS 2000. These data substantially improve the information available in 
production risk analysis.   
In order that the variability in profits could be accessed, price and cost assumptions 
are necessary. Packers published the relationship between prices they pay and live market 
weight of hogs. These packer price matrixes have been used by Boland (1996), USDA 
(1995) and Miller et al. (2001), to mention a few. Here we use the same price matrix as 
Miller et al. (2001). Under our pricing matrix, market pigs are divided into lightweight,  
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standard weight and overweight groups. Penalty prices are imposed on lightweight and 
overweight pigs based on the weight difference from the standard range. The price matrix 
is shown in table 1 (table 4 in Miller et al., 2001). 
Production costs are assumed to be those given for the grower/finisher stage from 
USDA (2000) and costs of antibiotics from Cromwell (2001). The production costs per 
hundred pounds of live market weights included feed costs, other operating costs and 
allocated overhead; costs from 1995-99 were averaged and used in the estimation of 
economic returns. Antibiotic costs were based on cost of chlortetracycline at $0.03 per 
gram at 50 grams per ton of feed. Feed intake was using the feed conversation rate (FCR) 
from NAHMS 2000 data; the antibiotic costs are estimated to be $0.0042 per day per pig. 
 
Results and Discussions 
Production risk impacts 
Our empirical analysis begins with two econometric models:   
(3.1)   ) ........ 3 , 2 , 1 ( 1 k x x x x f ADG =  
(3.2)   ) ........ 3 , 2 , 1 ( 2 ) ( k x x x x f y SD =  
Where ADG is the average daily gain and SD(y) represents standard deviation of live 
weight.  k x x x x ........ 3 , 2 , 1  is a set of controllable input. Using OLS, the relationships 
between ADG and SD(y) with antibiotic use and other production inputs are established 
(see table 2 and table 3 ).  
The use of antibiotics contributes to expected live market weight (derived from 
estimates of ADG) and the variability of market weight. For E(y), expected market  
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weight, the impact from antibiotic use is in a quadratic function. For SD(y), the effect 
from antibiotic use is fitted well with a cubic function.  
Using the parameters, we estimate live market weight and standard deviation in live 
market weight for different times antibiotics are fed, ranging from 0 to 110 days. The 
impacts on expected live market weight from sub-therapeutic use of antibiotics are 
positive in the range of consideration (Figure 1). Marginal weight gains are positive with 
antibiotic use less than 85 days. Marginal weight gains approach zero with antibiotics fed 
at about 85 days, and marginal weight gain becomes negative after that. The impacts 
from antibiotic use demonstrate a steady marginal reduction in the variance of live 
market weight for antibiotic use from 1 to 50 days. Beyond that, the marginal effect 
becomes positive, but the average risk reduction effects from antibiotic use continue until 
120 days. In other words, average risk reduction continues essentially through the entire 
period. 
 
Decision Use under Utility Maximization  
Based on the profit function (equation (1.2)), profits per pig with varying antibiotic use 
are estimated. We present estimates of the means, SD and skewness of profits. We 
assume no risk on the market side, i.e. fixed and known market prices. But hog prices do 
vary with live market weight according to the assumed pricing matrix (table1). While 
other hog attributes affect the market price received, we concentrated our analyses on the 
live market weight as the attribute of overwhelming importance.  
Profits, even in the case of no market risk, become a random variable with a non-normal 
distribution based on the negative skewness under all cases, although a normal  
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distribution of live market weight is assumed. All three moments of the profit distribution 
vary with the number of days antibiotics are fed. A risk neutral swine producer would 
make his decision based on the average profits (Dillon); our analysis suggests the level of 
antibiotic use be 60 days in the grow-finish stage. However, the decision making of a risk 
averse swine producers will also consider the variance of profits. 
We assume a risk averse swine producer has a quadratic utility given by: 
(3.3)  u (π) = π + b π 
2   
where b represents the producers risk aversion coefficient. Thus, the expected utility of a 
swine producer is given by: 
(3.4)  E  (u  (π)) = E (π) + b E (π 
2) = E (π)  + b (E (π)) 
2 + b V (π) 
Given E (π) and V (π) (table 4), the utility of a swine producer is estimated (Table 5) 
based on days antibiotics are fed and various risk aversion coefficients. 
  The results on expected profit and expected utility  (table 4 and table 5) illustrate 
some relationships between production risk and the use of antibiotics in U.S. swine 
production. First, the utility value of swine producers is sensitive to changes in number of 
days antibiotics are fed. Lower and higher antibiotic feeding days correspond to higher 
production risk (figure 1) and lower utility. The middle level of antibiotic use days is 
associated with higher profits, decreased risk and higher utility. Second, risk aversion 
coefficients affect the utility values, but varying the coefficients does not change the 
result in most cases. Among the seven risk aversion parameters, five support the selection 
of efficient fed time in the range of 60 days. When the risk aversion coefficient is larger 
than 0.01, the decision process was not modeled well with a quadratic utility assumption. 
Third, the variance of live market weight affects the selection of antibiotics as an input.   
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The results of this study provide evidence that swine producers have incentive to use 
antibiotics sub-therapeutically in order to decrease live market weight variability. If the 
decision is based only on an increase in live market weight, the optimal time of antibiotic 
use is about 85 days. However, when the variance of live-weight was taken into 
consideration, the efficient fed time of antibiotics reduced to about 60 days if all pigs 
from a barn are marketed simultaneously.  
 
Decision under Stochastic Dominance 
We use stochastic dominance analysis to further test results from the expected utility 
analyses. The quadratic utility functional form is useful to model the behavior of 
producers with a risk aversion coefficient less than 0.01, but is ill behaved with a risk 
aversion coefficient larger than 0.01 where the marginal utility from an extra unit of 
profits become negative. Considering other alternatives of utility specification and the 
non-normal distribution of profits, stochastic dominance analysis was used to further test 
the results. 
We obtain a profit distribution under each feeding scenario. Based on the 
econometric estimates, a normal live market weight distribution with simultaneous 
marketing of all pigs in a farm with known E(q) and V(q) was established for each case of 
antibiotic application. Using @RISK software, we model live market weight samples of 
five thousand from each live market weight distribution. With each of these samples, a 
profit distribution is derived. We obtained twelve profit distributions. Three major profit 
distributions are shown graphically  (figure 2).   
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Within the domain of profits, FSD does not occur between any pair of distributions 
under varying levels of antibiotic use. No stochastic dominant relationship occurred 
among adjacent pairs of distributions. Two profit distributions with 60 and 70 days of 
antibiotic fed time overlapped with each other. They are second order dominant to most 
other distributions, including the distributions from lower and higher antibiotic use. The 
profit distribution with 60 days of antibiotic use appears to represents the most preferred 
selection. 
SSD suggests that the risk averse swine producer would likely to reduce risk and 
improve their utility by using antibiotics. Under the assumption of simultaneous 
marketing, the preferred number of days antibiotics would be fed are for about one half of 
the feeding period (60-70 days of 114 days total).  
The distribution with 70 days of antibiotic use is approximately first order dominant 
to the profit distribution with no antibiotic use. With twenty tests conducted in the profit 
range, only one has a t-value of 1.93, all others are larger than 2. This suggests that U.S. 
swine producers, no matter what their risk preference, will benefit from antibiotic use and 
have willingness to use antibiotics at sub-therapeutic levels.  
The results of SD are similar to our earlier conclusions using expected utility 
analysis. These further confirm the preference of U.S. swine producers to using 
antibiotics in the grow/finish stage to reduce production risk and maximize utility.  
 
Caveats of our analysis 
This study represents an initial effort to analyze quantitatively the production risk from 
variation in live market weight of hogs. The conclusions enhance the insight into the  
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understanding of production risk associated with variation of live market weight. 
However, the lack of information and assumptions used in the study make caveats 
necessary to help prevent over interpretation of the results.  
First, the study assumes that pigs are marketed simultaneously. However, the reality 
is that swine producers usually market pigs from a barn over a period of time. Pigs are 
shipped as a truckload reaches optimal market weight. Therefore, our estimates of weight 
variation of market hogs obtained are theoretically biased. The degree of bias depends on 
the perspective and is difficult to ascertain. We believe our estimated standard deviation 
is higher than will be seen by producers who market over a period of time. But also, our 
estimated standard deviation is lower than would be realized by a producer who did 
actually market all pigs from a barn at one point in time. 
Second, swine producers sometimes reduce the proportion of lightweight market pigs 
by extending the days to slaughter in the grower/finisher stage. There are tradeoffs 
between production risk and the costs for extending time to slaughter. A model expansion 
that could bridge the tradeoff between risk and costs may offer more empirical guidance 
to swine producers and policy regulators. 
Third, average daily gain, entry age and marketing age in NAHMS 2000 are the data 
sources available for calculating live market weight at the farm. Data quality is a concern 
considering the large number of missing values and high proportion of data without 
documented sources. However, there seems to be minimal biases at least related to farm 
size from missing data (Miller et al., 2003). 
These data deficiencies and assumptions may make interpretation of results more 
difficult. The magnitude of such bias and efficiency is not assessed.    
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Conclusions 
Production risks from variability in live market weight of hogs measures an important 
dimension of swine production. Live market weight variability significantly affects the 
profits of swine producers. The variability in live market weight, associated with 
uncertain inputs, could be partially controlled by adjusting sub-therapeutic antibiotic use.  
Antibiotic use at all levels could be used to reduce production risk. The most effective 
and profitable application is about 60-70 days. This is slightly less than the mean of 72 
days of antibiotics currently used by producers (NAHMS 2000 data). 
Sub-therapeutic use of antibiotics is preferred by swine producers on each of the 
criteria, including live market weight, profits, utility, and stochastic dominance. If only 
expected live market weight is considered, swine producers prefer a relatively large 
number of days sub-therapeutic antibiotics are fed; the number becomes substantial less 
when the variation in live market weight is considered. However, in all cases, swine 
producers would prefer to use sub-therapeutic antibiotics in swine production.      
The incentive we examined is due to the impacts of antibiotic use on reducing the 
production risk and enhancing average profits. Other incentives not examined directly 
include the influence that antibiotic use might have on decreasing swine diseases, 
enhancing overall swine health and any direct influence this might have on price 
premiums received by producers.     
Our analyses suggest that a ban on the sub-therapeutic use of antibiotics would not 
be preferred by swine producers. However, public concerns about antibiotic use in swine 
production are important to consider. Further investigation of the contribution of routine  
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Table 1. Price matrix of market weight hogs  
Weight class  Price penalty ($/cwt)  Weight class  Price penalty ($/cwt) 
<190  7  261 – 271  0 
191 – 201  7  271 – 281  0 
201 – 211  5  281 – 291  0.5 
211 – 221  3  291 – 301  1.5 
221 – 230  1  301 – 311  2.5 
230 – 241  0  311 – 321  4.5 
241 – 251  0  320 <  6.5 
251 – 261  0     
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Table 2.  Variables associate with average daily gain   
Variable  Description  Estimate  T Value           Pr > |t| 
Intercept    1.625  32.39  <.0001 
Abxday  Time length of antibiotic use   0.0015  2.76  0.01 
AbxdaySQ2  Quadratic term of antibiotic use  -8.E-06  -2.34  0.02 
Dcontract  Producer contract dummy  -0.016  -0.63  0.52 
Daiao  All-in-all-out system dummy  0.016  0.77  0.44 
Off_site2  Off site source dummy  -0.063  -1.28  0.20 
RestrictNum  Number of bio security measurements  0.014  2.64  0.01 
DeathreasonNum  Number of reasons given for big death  -0.014  -2.27  0.02 
Dration3_4  Using 3-4 different rations  0.020  0.59  0.55 
Dration5_up  Using 5 or more different rations  0.041  1.23  0.22 
VaccNum  Num. of vaccinations  -0.005  -1.27  0.20 
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Table 3.  Variables associated with Standard deviation of live market weight 
Variable  Description  Estimate  T value  Pr > |t| 
Intercept    5.648  1.37  0.173 
Abxday  Time length of antibiotic use  -0.187  -2.2  0.029 
AbxdaySQ2  Quadratic term of antibiotic use  0.003  2.25  0.025 
AbxdaySQ3  Cubic term of antibiotic use  -8.E-06  -2.07  0.039 
Env-testNum   Num. of air, water tests  0.316  2.82  0.005 
VetvisitNum  Num. of veterinary visits  0.424  0.48  0.631 
Daiao  All-in-all-out   2.790  1.8  0.073 
Dcontract  Contact producer  2.245  1.3  0.196 
Northern  Northern region  -1.866  -0.99  0.321 
WestCentral  West central Region  -6.878  -3.98  <.0001 
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Table 4. Mean, SD and skewness of profit per pig with varying number of days 











Days antibiotics are fed  Mean Standard  deviation  Skewness 
 0  10.18  4.11  -2.25 
10  10.73  3.84  -2.41 
20  11.17  3.63  -2.53 
30  11.50  3.51  -2.62 
40  11.73  3.45  -2.66 
50  11.87  3.45  -2.66 
60  11.93  3.51  -2.62 
70  11.91  3.63  -2.55 
80  11.81  3.77  -2.45 
90  11.66  3.93  -2.36 
100  11.44  4.11  -2.25 
110  11.17  4.31  -2.14  
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Table 5. Utility under varying antibiotics use  
         Risk aversion coefficient       
Days antibiotics are fed   -0.10 -0.05 -0.01  -0.005  -0.001  -0.0005  -0.0001 
0   -0.18  5.00  9.14  9.66  10.07  10.12  10.16 
10    -0.78  4.97  9.58  10.15  10.61  10.67  10.72 
20    -1.30  4.93  9.92  10.54  11.04  11.10  11.15 
30    -1.72  4.89  10.17  10.84  11.36  11.43  11.48 
40    -2.02  4.85  10.35  11.04  11.59  11.66  11.71 
50    -2.22  4.82  10.46  11.17  11.73  11.80  11.86 
60    -2.31  4.81  10.51  11.22  11.79  11.86  11.92 
70    -2.27  4.82  10.49  11.20  11.77  11.84  11.89 
80    -2.14  4.84  10.42  11.12  11.67  11.74  11.80 
90    -1.94  4.86  10.30  10.98  11.52  11.59  11.65 
100    -1.65  4.90  10.13  10.79  11.31  11.37  11.43 
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Distribution 1 Distribution 2 Distribution 3
 
  Figure 2. Profit distribution with varying use of antibiotics (Distributions 1, 2 and 3 
represent profit distributions with 0, 60 and 110 days of antibiotic use respectively)  
 
 